Novartis reported 45.72B in Current Assets for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Alcon AG ALC:SW 5.39B 96M
AstraZeneca AZN:LN 26.24B 447M
Bayer BAYN:GR 32.58B 633M
Fresenius FRE:GR € 17461M 127M
Galapagos GLPG:NA 4.86B 154.14M
Genmab GEN:DC 23.18B 439M
GRIFOLS GRF:SM € 3239.5M 153.93M
Hikma Pharmaceutical HIK:LN 2.09B 139M
Lonza Group LONN:SW 5.96B 925M
Novartis NOVN:VX 45.72B 19.46B
Orion ORNBV:FH 690.3M 87.6M
Recordati REC:IM 958.12M 50.73M